analyst
SG
NASDAQ · SGRY
Surgery Partners, Inc.
Healthcare · Medical - Care Facilities
$13.25
Down-$0.10 (-0.75%)
Updated Sep 19, 2026, 9:23 PM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.08B
- P/E ratio
- -11.91
- Dividend yield
- 0.00%
- 52-week range
- $11.41 – $23.44
- Volume
- 2.75M
- Avg. volume
- 1.71M
Price performance
SGRY price history
1M range · 20 trading sessions · Daily adjusted prices
SGRY closed at $13.25 after 20 trading sessions, down 8.75% for the selected period.
- Last close
- $13.25
- Period change
- -8.75%
- Period low
- $13.25
- Period high
- $14.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $13.12 | $13.485 | $12.9655 | $13.25 | 2.75M |
| Sep 17, 2026 | $14.10 | $14.15 | $13.255 | $13.35 | 3.81M |
| Sep 16, 2026 | $13.71 | $14.24 | $13.60 | $13.93 | 1.48M |
| Sep 15, 2026 | $13.97 | $14.16 | $13.56 | $13.65 | 1.91M |
| Sep 14, 2026 | $14.44 | $14.73 | $14.015 | $14.04 | 2.16M |
| Sep 11, 2026 | $14.23 | $14.60 | $14.03 | $14.38 | 1.29M |
| Sep 10, 2026 | $14.10 | $14.18 | $13.72 | $14.12 | 3.28M |
| Sep 9, 2026 | $13.87 | $14.49 | $13.592 | $14.12 | 1.68M |
| Sep 8, 2026 | $14.19 | $14.41 | $13.90 | $13.96 | 2.05M |
| Sep 4, 2026 | $14.17 | $14.51 | $14.06 | $14.26 | 1.11M |
| Sep 3, 2026 | $14.13 | $14.37 | $13.875 | $14.17 | 1.63M |
| Sep 2, 2026 | $14.58 | $14.72 | $13.91 | $13.98 | 2.21M |
| Sep 1, 2026 | $13.89 | $15.08 | $13.78 | $14.60 | 3.96M |
| Aug 31, 2026 | $13.65 | $13.93 | $13.18 | $13.89 | 3.92M |
| Aug 28, 2026 | $13.87 | $13.98 | $13.515 | $13.69 | 2.04M |
| Aug 27, 2026 | $13.90 | $14.10 | $13.68 | $13.93 | 1.37M |
| Aug 26, 2026 | $14.01 | $14.39 | $14.00 | $14.04 | 3.3M |
| Aug 25, 2026 | $13.75 | $14.08 | $13.75 | $14.05 | 2.27M |
| Aug 24, 2026 | $14.55 | $14.8034 | $13.92 | $13.95 | 2.15M |
| Aug 21, 2026 | $14.10 | $14.55 | $13.79 | $14.52 | 3.88M |
Latest SGRY news
The latest Smart Investors Daily articles mentioning SGRY.
Stock researchResearch & News · Competitors
Loading stock research…

